November 30th – December 1st, 2016
The Matera Resolution was drafted in April 2016 by an inaugural group of advocates to create a strategy to improve the evidence base and applicability of drug trial results to women in real world settings.
The purpose of the Matera group meeting is to refine the strategy and develop recommendations to advocates and create a strategy to improve the evidence base and applicability of drug trial results to women in real world settings.
Recent research evidence and the various activities launched with different stakeholders, including regulatory and funding organizations, journal editors, government agencies, industry and patient sectors will be discussed.
Presidents of the Meeting
Prof. Flavia Franconi
Prof. Vera Regitz-Zagrosek
Prof. Cara Tannenbaum
Charité - Universitätsmedizin Berlin
Institute of Gender in Medicine (GIM)
Deutsche Gesellschaft für Geschlechtsspezifische Medizin e.V. (DGesGM)
CIHR Institute of Gender and Health